about
Differential effects of the estrogen receptor agonist estradiol on toxicity induced by enzymatically-derived or autoxidation-derived oxysterols in human ARPE-19 cells.Variability in short-wavelength automated perimetry among peri- or postmenopausal women: a dependence on phyto-oestrogen consumption?Breast cancer medications and vision: effects of treatments for early-stage disease.Ocular side effects of biological agents in oncology: what should the clinician be aware of?Dry eye syndrome in aromatase inhibitor users.Effects of sex and age on the normal retinal and choroidal structures on optical coherence tomography.Electroretinographic and optical coherence tomography findings in breast cancer patients using aromatase inhibitors.
P2860
Q33795949-F4D9AB92-0A48-47BF-A3DA-DDD7C6E47FCFQ33926453-91A15157-F4C0-4527-AA51-9B00D451D174Q35496778-33AFC054-76B9-40B7-B4E5-06CDAF989399Q37427522-9E0C2F19-C6C4-41D5-84C6-491EEECCAAB6Q38041583-6ADDD061-9EEC-48E4-92B5-1B1BBC3F3166Q38242942-48349FD8-B012-4C23-9D9F-B6E91DF77078Q45029964-DB9965A5-123A-4C30-BEF2-321202195192
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vitreo-retinal traction and anastrozole use.
@en
Vitreo-retinal traction and anastrozole use.
@nl
type
label
Vitreo-retinal traction and anastrozole use.
@en
Vitreo-retinal traction and anastrozole use.
@nl
prefLabel
Vitreo-retinal traction and anastrozole use.
@en
Vitreo-retinal traction and anastrozole use.
@nl
P2093
P2860
P1476
Vitreo-retinal traction and anastrozole use.
@en
P2093
Alvin Eisner
Emily J Thielman
John T Vetto
Julie Falardeau
P2860
P2888
P356
10.1007/S10549-008-0156-5
P407
P577
2008-08-20T00:00:00Z